IL6 and neoplasm: Our data demonstrate that OSM, a member of the IL-6 subfamily of cytokines, and components of the OSM signaling pathway are expressed in OSA cell lines and tumor samples, and that activation of the JAK/STAT3 pathway with OSM stimulation leads to increased production of MMP2, VEGF, and enhanced tumor cell invasion.